. Author manuscript; available in PMC: 2021 Nov 1.

Published in final edited form as: Gastroenterol Nurs. 2020 Nov-Dec;43(6):429–439. doi: 10.1097/SGA.0000000000000483

Table 4.

Interaction between Immunomodulators and Biological Medication for Tangible Received Social Support

Medication Status	Received tangible social support (95% Confidence Interval)
Immunomodulator only	36.7 (36.0, 37.5)
Immunomodulator plus biologic	23.2 (19.1, 27.3)
Biological only	22.4 (19.9, 24.9)
Not immunomodulator or biologic	17.0 (15.2, 18.8)

Note: Adjusted for time since diagnosis (centered at 76.3) and symptom interference (centered at 1.1). Emerging adults on immunomodulator medication alone have the greatest receipt of tangible social support.